Moxifloxacin versus amoxicillin/clavulanic acid in outpatient acute exacerbations of COPD: MAESTRAL results. - Wikidata - awgldk - TriplyDB

Moxifloxacin versus amoxicillin/clavulanic acid in outpatient acute exacerbations of COPD: MAESTRAL results.

Moxifloxacin versus amoxicillin/clavulanic acid in outpatient acute exacerbations of COPD: MAESTRAL results.

http://www.wikidata.org/entity/Q36087058

about

Antibiotics for exacerbations of chronic obstructive pulmonary disease Bronchiectasis as a Comorbidity of Chronic Obstructive Pulmonary Disease: A Systematic Review and Meta-Analysis Moxifloxacin modulates inflammation during murine pneumonia.Efficacy and safety of moxifloxacin in acute exacerbations of chronic bronchitis: a prospective, multicenter, observational study (AVANTI)Antibiotic Prescription for COPD Exacerbations Admitted to Hospital: European COPD Audit Prognostic factors for clinical failure of exacerbations in elderly outpatients with moderate-to-severe COPD.Fluoroquinolones versus β-Lactam/β-Lactamase Inhibitors in Outpatients with Chronic Obstructive Pulmonary Disease and Pneumonia: A Nationwide Population-Based Study Impact of Prolonged Exacerbation Recovery in Chronic Obstructive Pulmonary Disease.Determinants of bacteriological outcomes in exacerbations of chronic obstructive pulmonary disease.The Belgian trial with azithromycin for acute COPD exacerbations requiring hospitalization: an investigator-initiated study protocol for a multicenter, randomized, double-blind, placebo-controlled trial Pharmacological Management and Prevention Of Exacerbations of Chronic Obstructive Pulmonary Disease in Hospitalized Patients.Effect of levofloxacin on neutrophilic airway inflammation in stable COPD: a randomized, double-blind, placebo-controlled trial.Efficacy and safety of moxifloxacin in acute exacerbations of chronic bronchitis and COPD: a systematic review and meta-analysis The use of moxifloxacin for acute exacerbations of chronic obstructive pulmonary disease and chronic bronchitis.The pharmacological approach to the elderly COPD patient.Biomarkers that predict and guide therapy for exacerbations of chronic obstructive pulmonary disease.Pharmacotherapy for lower respiratory tract infections.Chronic Respiratory Infection in Patients with Chronic Obstructive Pulmonary Disease: What Is the Role of Antibiotics?Antibiotics for acute and chronic respiratory infection in patients with chronic obstructive pulmonary disease.Predictors for antibiotic prescribing in patients with exacerbations of COPD in general practice.Predicting In-Hospital Treatment Failure (≤ 7 days) in Patients with COPD Exacerbation Using Antibiotics and Systemic Steroids.The Clinical Management Of Lower Respiratory Tract Infections.Acute exacerbations of COPD: risk factors for failure and relapse.Comparison of the clinical characteristics and treatment outcomes of patients requiring hospital admission to treat eosinophilic and neutrophilic exacerbations of COPD.Chronic obstructive pulmonary disease and infection. Disruption of the microbiome?Antibiotics for treatment of acute exacerbation of chronic obstructive pulmonary disease: a network meta-analysis.Treatment of exacerbations as a predictor of subsequent outcomes in patients with COPD.Clinical Outcomes and Cost Analysis of Exacerbations in Chronic Obstructive Pulmonary Disease Efficacy of Antibiotic Therapy for Acute Exacerbations of Mild to Moderate Chronic Obstructive Pulmonary Disease

P2860

Q24202248-5C66C9C0-508B-43EF-8E7A-535C3A1B663D Q26765486-EF4A35E9-DCCD-4FF2-A65E-B216093D625C Q33986123-3343F23E-40DE-42EC-9846-0359123796AB Q34560033-F475B73E-03B0-4C0C-A94C-1F532C27E377 Q35533063-822C3E2E-0DAE-4A80-9E73-9C52894DE57E Q35694431-C036B010-7518-432E-B38D-F26AA0C47145 Q35754952-BFAF38C6-C861-4F51-BB62-A8087A03C8D8 Q36272425-6069EA6B-9AB0-4028-8B20-40BD581E64B2 Q36526951-4755C29D-E8DD-4E32-8E47-B3396BBB6CD0 Q36763617-48FB0770-576E-4505-8104-F4B26D6336E9 Q37372207-E54E9189-6A58-4A10-B17C-E0571691C58D Q37582484-F2457ECF-6C5F-4CA1-951C-AA446191B196 Q37629535-4A82E7B3-93F3-4431-81C1-D1D1B2CCC08A Q38056764-A6AA43B4-2F24-4C9B-A290-7CCCE8C2A261 Q38098479-ED739CAB-AD7E-4348-9E9B-1EA41FD3993B Q38169246-B2DE3687-F1FF-4520-8E3F-9612B8DCF3E9 Q38248719-C12B283D-E2F2-4184-8A4C-A90CA59EFC80 Q38667550-7BCEC4BA-7C08-4A2D-BE1A-D93F7147A660 Q39370816-E8385775-E8C0-4032-B9BA-DA1F514A8112 Q40260675-33D5D498-879E-4632-9C63-A8132A750EC3 Q40448715-A2CE4D06-5B29-4A6D-9B53-40D93D6D4251 Q40785029-A9F540E3-CF7D-4675-AAB2-4584730E7561 Q41072489-543285E5-37EB-4B77-841F-1935AFE84D39 Q41367451-97EB485C-E2FA-43F6-9D45-4CEE159808FD Q43518845-CD66D2DC-5BC0-433F-81E9-8D98BFC78F92 Q47127548-44B578BD-9113-42E5-BA01-F3C9326E7426 Q54998966-BE489AE9-1A1B-44F9-B097-EAB6E053AB28 Q57777724-99935385-988A-4841-A677-BB296B4B7456 Q57777851-E654760B-B1AB-4769-ADBA-97D2D900FB87

P2860

Moxifloxacin versus amoxicillin/clavulanic acid in outpatient acute exacerbations of COPD: MAESTRAL results.

http://www.wikidata.org/entity/Q36087058

description

2011 nî lūn-bûn

@nan

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

2011年论文

@zh

2011年论文

@zh-cn

name

Moxifloxacin versus amoxicilli ...... ons of COPD: MAESTRAL results.

@ast

Moxifloxacin versus amoxicilli ...... ons of COPD: MAESTRAL results.

@en

type

label

Moxifloxacin versus amoxicilli ...... ons of COPD: MAESTRAL results.

@ast

Moxifloxacin versus amoxicilli ...... ons of COPD: MAESTRAL results.

@en

prefLabel

Moxifloxacin versus amoxicilli ...... ons of COPD: MAESTRAL results.

@ast

Moxifloxacin versus amoxicilli ...... ons of COPD: MAESTRAL results.

@en

P1433

Q36087058-903A672A-A1E7-44E6-ACB3-5755EC4FC42B

P1476

Q36087058-8FBD5642-0261-49EB-A7E4-E473DE088932

P2093

Q36087058-08500474-5865-4CD4-89FD-95F06E4E82CE

Q36087058-1A1F12E9-BC52-4EB2-B557-3D84FBDA7B99

Q36087058-8E17F751-5129-4B4D-9A73-E034C47FF5CA

Q36087058-B031ADD8-123F-426A-B0FC-4ADBDBBE553A

Q36087058-BA21DE6E-D342-4094-A125-1177ED150C62

Q36087058-E8BE5A1A-2055-40E3-B7AC-38A40F34F31A

P2860

Q36087058-0A2C49DD-CF10-44E9-92ED-4D25149736E0

Q36087058-2AF948EF-12CB-4918-8289-5507C7E528E5

Q36087058-2C231A3D-358A-41C3-B6B7-66A75399EBB5

Q36087058-2E4A63C3-AD71-44E4-8D2B-B256911778EC

Q36087058-37AD632F-15E6-482E-AB90-41666A630573

Q36087058-3E628AAE-D7A0-42C8-8D67-1A5A463255D9

Q36087058-40296BCF-179E-4C76-8F64-64AC40119279

Q36087058-4DF57C1B-52C9-4309-B269-D454CF507EE9

Q36087058-51F7BFD6-AE54-4AD6-94A5-DBA9DF4BD25C

Q36087058-5A812D4D-26E2-432A-AF34-8A3FB56610F1

P304

Q36087058-BD1EB578-51CB-4186-9DA1-C22FA8DF71CF

P31

Q36087058-7338C4BE-8397-4854-8F1B-2CE750B42B63

P356

Q36087058-596E4659-306D-49C1-9BF5-A0C74337367F

P433

Q36087058-B4E63240-5B85-4A08-816F-09E8C53866E0

P478

Q36087058-4D0C46AF-5497-484A-A40F-5A6E6054B448

P50

Q36087058-138FAAEF-4EDB-4C56-B179-D1EC8F67346D

Q36087058-513B027C-7A0F-4103-AFC4-38018F66CEE2

P577

Q36087058-E3DD38DE-43B6-4EC4-AE5E-43A59F19A1BF

P5875

Q36087058-C11C64E3-CAC7-4E57-B956-CAB8670B6E36

P698

Q36087058-40EEAEB4-A96A-4707-B273-7C0E72A80DE4

P932

Q36087058-EAF32223-38F8-42AC-863C-AD1B06A7D03F

P356

09031936.00090311

P1433

European Respiratory Journal

P1476

Moxifloxacin versus amoxicilli ...... ons of COPD: MAESTRAL results.

@en

P2093

Daniel Haverstock

http://www.w3.org/2001/XMLSchema#string

Jeff Alder

http://www.w3.org/2001/XMLSchema#string

Mila Trajanovic

http://www.w3.org/2001/XMLSchema#string

Pierre Arvis

http://www.w3.org/2001/XMLSchema#string

Robert Wilson

http://www.w3.org/2001/XMLSchema#string

Sanjay Sethi

http://www.w3.org/2001/XMLSchema#string

P2860

Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper

Canadian Thoracic Society recommendations for management of chronic obstructive pulmonary disease - 2008 update - highlights for primary care

Clinical and economic considerations in the treatment of acute exacerbations of chronic bronchitis.

Antibiotic therapy in exacerbations of chronic obstructive pulmonary disease.

Relationship of sputum color to nature and outpatient management of acute exacerbations of COPD.

Guidelines for the management of adult lower respiratory tract infections.

Comparison of first-line with second-line antibiotics for acute exacerbations of chronic bronchitis: a metaanalysis of randomized controlled trials.

Clinical and bacteriological efficacy in treatment of acute exacerbations of chronic bronchitis with cefditoren-pivoxil versus cefuroxime-axetil

Introduction: historical perspective and development of amoxicillin/clavulanate.

Antibiotics in the treatment of acute exacerbations of chronic bronchitis.

P304

17-27

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1183/09031936.00090311

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

40

http://www.w3.org/2001/XMLSchema#string

P50

Marc Miravitlles

Antonio Anzueto

P577

2011-12-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51847558

http://www.w3.org/2001/XMLSchema#string

P698

22135277

http://www.w3.org/2001/XMLSchema#string

P932

3393767

http://www.w3.org/2001/XMLSchema#string